Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Ballintyn Rhonda Germany, Director. Director active across 3 companies, notably Integra Lifesciences Holdings CORP. In total, 5 reports have been logged. History available since 14 May 2021. The latest transaction was disclosed on 1 August 2023 (Disposition). Regulator: SEC (Form 4). The full history is free.
5 of 5 declarations
Rhonda Germany Ballintyn serves as a Board Member at Integra Lifesciences Holdings Corp and Aegion Corp. She has significant experience in the health and infrastructure sectors. As a board member, Rhonda contributes to the strategic direction of the companies, ensuring regulatory compliance and innovation. Her expertise is essential in guiding strategic decisions.